Harrow Investor Relations Material
Latest events
Q2 2025
Harrow
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Harrow Inc
Access all reports
Harrow Health Inc is a pharmaceutical company focused on the development and commercialization of ophthalmic pharmaceutical products. The company offers compounded medications and branded formulations for use in eye care. It serves physicians, clinics, and surgical centers in the United States. The company is headquartered in Nashville, Tennessee, and its shares are listed on the NASDAQ.
Key slides for Harrow Inc
Q1 2025
Harrow Inc
Q2 2025
Harrow Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
HROW
Country
🇺🇸 United States